Tel Aviv. Photo: wiki commons.

Tel Aviv will be hosting the BioMed 2012 conference May 21-23 to display advancements in the biotechnology industry, including in stem-cell research. Sixty Israeli medical device and biopharmaceutical companies will present at the conference to about 6,000 visitors, reported the Times of Israel.

Israel has made notable advancements in the biopharmaceutical and stem cell research industries. Recently, Hadassah Ein Kerem Hospital doctors succeeded in significantly increasing the number of red blood cells in a 7-year-old girl suffering from aplastic bone marrow. The disease was impeding her body from manufacturing new red blood cells.

Also recently, the U.S. Food and Drug Administration (FDA) approved a drug developed by Israel’s Protalix to treat Gaucher’s disease.